CANNARA BIOTECH INC (LOVE.CA) Fundamental Analysis & Valuation

TSX-V:LOVE • CA13765U2002

Current stock price

1.92 CAD
-0.13 (-6.34%)
Last:

This LOVE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LOVE.CA Profitability Analysis

1.1 Basic Checks

  • LOVE had positive earnings in the past year.
  • In the past year LOVE had a positive cash flow from operations.
  • LOVE had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M -30M

1.2 Ratios

  • The Return On Assets of LOVE (6.79%) is better than 100.00% of its industry peers.
  • LOVE has a Return On Equity (10.62%) which is in line with its industry peers.
Industry RankSector Rank
ROA 6.79%
ROE 10.62%
ROIC N/A
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • LOVE's Profit Margin of 10.51% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
  • LOVE's Profit Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 17.92%, LOVE is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LOVE has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.51%
GM 17.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. LOVE.CA Health Analysis

2.1 Basic Checks

  • LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LOVE has more shares outstanding than it did 1 year ago.
  • LOVE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LOVE has been reduced compared to a year ago.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • LOVE has an Altman-Z score of 2.64. This is not the best score and indicates that LOVE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LOVE's Altman-Z score of 2.64 is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
  • The Debt to FCF ratio of LOVE is 2.53, which is a good value as it means it would take LOVE, 2.53 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.53, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • LOVE has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • LOVE has a Debt to Equity ratio of 0.29. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.53
Altman-Z 2.64
ROIC/WACCN/A
WACC7.38%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 2.70 indicates that LOVE has no problem at all paying its short term obligations.
  • LOVE has a Current ratio of 2.70. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
  • A Quick Ratio of 1.05 indicates that LOVE should not have too much problems paying its short term obligations.
  • LOVE has a Quick ratio of 1.05. This is comparable to the rest of the industry: LOVE outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.7
Quick Ratio 1.05
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. LOVE.CA Growth Analysis

3.1 Past

  • LOVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.50%, which is quite impressive.
  • Measured over the past years, LOVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 75.27% on average per year.
  • LOVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.06%.
  • The Revenue has been growing by 110.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.5%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-57.14%
Revenue 1Y (TTM)28.06%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.14% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LOVE will show a quite strong growth in Revenue. The Revenue will grow by 18.32% on average per year.
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3Y39.14%
EPS Next 5YN/A
Revenue Next Year22.42%
Revenue Next 2Y16.79%
Revenue Next 3Y18.32%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
LOVE.CA Yearly EPS VS EstimatesLOVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.05 0.1 0.15 0.2 0.25

More info and screens

Find the best growth stocksShow best growing peers

7

4. LOVE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.77 indicates a correct valuation of LOVE.
  • 100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.33, LOVE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 9.50, which indicates a very decent valuation of LOVE.
  • Based on the Price/Forward Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • LOVE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.16.
Industry RankSector Rank
PE 14.77
Fwd PE 9.5
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, LOVE is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.36
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • LOVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LOVE's earnings are expected to grow with 39.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y39.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LOVE.CA Dividend Analysis

5.1 Amount

  • No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LOVE.CA Fundamentals: All Metrics, Ratios and Statistics

CANNARA BIOTECH INC

TSX-V:LOVE (4/14/2026, 7:00:00 PM)

1.92

-0.13 (-6.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-14
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap183.90M
Revenue(TTM)112.36M
Net Income(TTM)11.81M
Analysts80
Price Target3.57 (85.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.05%
Valuation
Industry RankSector Rank
PE 14.77
Fwd PE 9.5
P/S 1.64
P/FCF 13.36
P/OCF 8.31
P/B 1.65
P/tB 1.65
EV/EBITDA N/A
EPS(TTM)0.13
EY6.77%
EPS(NY)0.2
Fwd EY10.52%
FCF(TTM)0.14
FCFY7.49%
OCF(TTM)0.23
OCFY12.04%
SpS1.17
BVpS1.16
TBVpS1.16
PEG (NY)0.25
PEG (5Y)N/A
Graham Number1.84
Profitability
Industry RankSector Rank
ROA 6.79%
ROE 10.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.51%
GM 17.92%
FCFM 12.25%
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.53
Debt/EBITDA N/A
Cap/Depr 124.72%
Cap/Sales 7.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 116.58%
Current Ratio 2.7
Quick Ratio 1.05
Altman-Z 2.64
F-Score8
WACC7.38%
ROIC/WACCN/A
Cap/Depr(3y)124.47%
Cap/Depr(5y)353.96%
Cap/Sales(3y)9.79%
Cap/Sales(5y)49.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.5%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-57.14%
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3Y39.14%
EPS Next 5YN/A
Revenue 1Y (TTM)28.06%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.11%
Revenue Next Year22.42%
Revenue Next 2Y16.79%
Revenue Next 3Y18.32%
Revenue Next 5YN/A
EBIT growth 1Y52.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.75%
EBIT Next 3Y34.1%
EBIT Next 5YN/A
FCF growth 1Y702.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y262.58%
OCF growth 3YN/A
OCF growth 5YN/A

CANNARA BIOTECH INC / LOVE.CA Fundamental Analysis FAQ

What is the fundamental rating for LOVE stock?

ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA.


What is the valuation status of CANNARA BIOTECH INC (LOVE.CA) stock?

ChartMill assigns a valuation rating of 7 / 10 to CANNARA BIOTECH INC (LOVE.CA). This can be considered as Undervalued.


How profitable is CANNARA BIOTECH INC (LOVE.CA) stock?

CANNARA BIOTECH INC (LOVE.CA) has a profitability rating of 4 / 10.


What is the valuation of CANNARA BIOTECH INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CANNARA BIOTECH INC (LOVE.CA) is 14.77 and the Price/Book (PB) ratio is 1.65.


What is the expected EPS growth for CANNARA BIOTECH INC (LOVE.CA) stock?

The Earnings per Share (EPS) of CANNARA BIOTECH INC (LOVE.CA) is expected to grow by 60% in the next year.